Hims & Hers, the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has launched two new prescription offerings -- Topical Finasteride & Minoxidil Spray and Oral Spironolactone -- to provide women with more effective solutions to address hair loss, which 1 in 3 women -- roughly 30 million women in the US alone -- experience at some time in their lives.
“This launch is the direct result of Hers’ close relationship with our consumers, listening
to their health goals and what they feel is missing from the hair loss market,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “Our ability to continue to bring clinically-proven ingredients to market in a unique dosage form through innovative compounding preparations remains unparalleled.
We’ve made it our mission to destigmatize issues like hair loss so that women aren’t embarrassed to confidently take control of their health!" In recent years, medical experts have seen an increase in patients across the country suffering from stress-related hair loss.
Internet searches alone for hair loss have increased by 8 percent in the 12 months since February 2021 – an average of more than 829,000 times a month in the US alone.
Hers has made the commitment to be the ally women need to help win the battle against hair loss with the introduction of two new prescription products: Topical Finasteride & Minoxidil Spray : The new topical spray combines 3% Finasteride and 6% Minoxidil, two clinically proven ingredients into a single, easy-to-use, no-mess spot treatment spray designed specifically for use by women…
